Re: The UK-based company that’s striving to overcome the limitations of T cell receptor innovation
Pretenders? I can think of a few, one of which can just about copy and paste. Pretty sad and pathetic really. Anyway, their partners are Illumina, Great Ormond Street Hospital, Imperial College London, National Cancer Centre Singapore and Zelluna Immunotherapy.
Dr. Michelle Teng [CEO, Co-founder], has 20 years of R&D experience working on a breadth of projects from lead discovery to translational medicine.
Dr. Jacob Hurst [CTO, Co-founder], has 25 years of bioinformatics experience spanning across translational medicine, HIV, TCR and antibody repertoire analytics.
Dr. Bent Jakobsen [Director], CEO of Accession Therapeutics and founded Immunocore as well as Adaptimmune.
Dr. John McCafferty [Scientific Advisor], Founder of Cambridge Antibody Technology with Drs. Sir Gregory Winter [Nobel laureate] and David Chiswell. He also founded Maxion Tx and IonTas.
